Skip to main content
. 2023 May 24;16:1092913. doi: 10.3389/fnmol.2023.1092913

Figure 4.

Figure 4

Summary of in-vivo results achieved with circularised and chemically stabilised gRNA. Two wild-type and one disease model were used to evaluate the in-vivo efficacy of endogenous ADAR recruitment. All studies showed sustained on-target editing over a minimum of 2 and a maximum of 8 weeks.